What Clinical Trials Can Teach Us About the Development of More Resilient AI for Cybersecurity

Abstract

Policy-mandated, rigorously administered scientific testing is needed to provide transparency into the efficacy of artificial intelligence-–based (AI-based) cyber defense tools for consumers and to prioritize future research and development. In this article, we propose a model that is informed by our experience, urged forward by massive-scale cyberattacks, and inspired by parallel developments in the biomedical field and the unprecedentedly fast development of new vaccines to combat global pathogens.